Global Topical Analgesics

Topical Analgesics Comprehensive Study by Type (Prescription Pain Relief, Over-The-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, E-Commerce, Retail & Grocery Stores), Formulation (Cream, Gel, Spray, Patch, Others), Therapeutic Class (Non-Opioids, Opioids) Players and Region - Global Market Outlook to 2030

Topical Analgesics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Topical Analgesics
Topical analgesics are known as a pain medication that can directly be applied on the skin instead of being swallowed/injected or anything else. Topical pain medications utilized in different forms for different situations, though they are commonly adopted for the treatment of musculoskeletal pain and some types of neuropathic pain.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketNorth America
UnitValue (USD Million)
CAGR7.3%


The global Topical Analgesics market is strongly competitive and having a few leading players. In concern of the market share, some of the leading players are highly dominating the whole market. These leading players are highly investing in strategic collaborative initiatives to enhance their market share and improve their profitability. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Topical Analgesics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Johnson & Johnson (United States), Novartis AG (Switzerland), GlaxoSmithKline Plc. (United Kingdom), Pfizer Inc. (United States), Reckitt Benckiser Group Plc. (United Kingdom), Sanofi S.A. (France), Topical BioMedics, Inc. (United States) and AdvaCare Pharma (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sun Pharmaceutical Industries Ltd. (India), Abacus Health Products, Inc. (Canada) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Topical Analgesics market by Type (Prescription Pain Relief and Over-The-Counter Pain Relief) and Region.



On the basis of geography, the market of Topical Analgesics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2023. If we see Market by Distribution Channel, the sub-segment i.e. Pharmacies & Drug Stores will boost the Topical Analgesics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Formulation, the sub-segment i.e. Cream will boost the Topical Analgesics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapeutic Class, the sub-segment i.e. Non-Opioids will boost the Topical Analgesics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Online Purchasing Trends across the Globe

Market Growth Drivers:
Easy Availability of Customers, The rise in Cases of Arthritis and Many Other Bone-Related Conditions and High Adoption of Topical Pain Relief Products

Challenges:
Lack of Consumer Awareness

Restraints:
High Cost of Raw Materials

Opportunities:
Increasing Number of Manufacturers across the Globe

Market Leaders and their expansionary development strategies
In 2020, GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain Gel as an over-the-counter (OTC) topical analgesic for temporary relief of arthritis pain in the hands, wrists, elbows, feet and ankles. did. or the knee of an adult (18+).
In 2021, Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., has launched Salonpas Arthritis Pain Relief Gel, featuring the most prescribed topical analgesic clinically proven to relieve arthritis pain in the major joints. and In Mar 2019, Abacus Health Products, the company revealed its products known as CBDMEDIC. Basically, it is a topical medication by combining active pharmaceutical ingredients which include hemp extracts and other herbal moisturizers.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Topical Analgesics Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
By Distribution Channel
  • Pharmacies & Drug Stores
  • E-Commerce
  • Retail & Grocery Stores

By Formulation
  • Cream
  • Gel
  • Spray
  • Patch
  • Others

By Therapeutic Class
  • Non-Opioids
  • Opioids

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Easy Availability of Customers
      • 3.2.2. The rise in Cases of Arthritis and Many Other Bone-Related Conditions
      • 3.2.3. High Adoption of Topical Pain Relief Products
    • 3.3. Market Challenges
      • 3.3.1. Lack of Consumer Awareness
    • 3.4. Market Trends
      • 3.4.1. Rising Online Purchasing Trends across the Globe
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Topical Analgesics, by Type, Distribution Channel, Formulation, Therapeutic Class and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Topical Analgesics (Value)
      • 5.2.1. Global Topical Analgesics by: Type (Value)
        • 5.2.1.1. Prescription Pain Relief
        • 5.2.1.2. Over-The-Counter Pain Relief
      • 5.2.2. Global Topical Analgesics by: Distribution Channel (Value)
        • 5.2.2.1. Pharmacies & Drug Stores
        • 5.2.2.2. E-Commerce
        • 5.2.2.3. Retail & Grocery Stores
      • 5.2.3. Global Topical Analgesics by: Formulation (Value)
        • 5.2.3.1. Cream
        • 5.2.3.2. Gel
        • 5.2.3.3. Spray
        • 5.2.3.4. Patch
        • 5.2.3.5. Others
      • 5.2.4. Global Topical Analgesics by: Therapeutic Class (Value)
        • 5.2.4.1. Non-Opioids
        • 5.2.4.2. Opioids
      • 5.2.5. Global Topical Analgesics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Topical Analgesics (Volume)
      • 5.3.1. Global Topical Analgesics by: Type (Volume)
        • 5.3.1.1. Prescription Pain Relief
        • 5.3.1.2. Over-The-Counter Pain Relief
      • 5.3.2. Global Topical Analgesics by: Distribution Channel (Volume)
        • 5.3.2.1. Pharmacies & Drug Stores
        • 5.3.2.2. E-Commerce
        • 5.3.2.3. Retail & Grocery Stores
      • 5.3.3. Global Topical Analgesics by: Formulation (Volume)
        • 5.3.3.1. Cream
        • 5.3.3.2. Gel
        • 5.3.3.3. Spray
        • 5.3.3.4. Patch
        • 5.3.3.5. Others
      • 5.3.4. Global Topical Analgesics by: Therapeutic Class (Volume)
        • 5.3.4.1. Non-Opioids
        • 5.3.4.2. Opioids
      • 5.3.5. Global Topical Analgesics Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Topical Analgesics (Price)
      • 5.4.1. Global Topical Analgesics by: Type (Price)
  • 6. Topical Analgesics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Reckitt Benckiser Group Plc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi S.A. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Topical BioMedics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AdvaCare Pharma (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Topical Analgesics Sale, by Type, Distribution Channel, Formulation, Therapeutic Class and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Topical Analgesics (Value)
      • 7.2.1. Global Topical Analgesics by: Type (Value)
        • 7.2.1.1. Prescription Pain Relief
        • 7.2.1.2. Over-The-Counter Pain Relief
      • 7.2.2. Global Topical Analgesics by: Distribution Channel (Value)
        • 7.2.2.1. Pharmacies & Drug Stores
        • 7.2.2.2. E-Commerce
        • 7.2.2.3. Retail & Grocery Stores
      • 7.2.3. Global Topical Analgesics by: Formulation (Value)
        • 7.2.3.1. Cream
        • 7.2.3.2. Gel
        • 7.2.3.3. Spray
        • 7.2.3.4. Patch
        • 7.2.3.5. Others
      • 7.2.4. Global Topical Analgesics by: Therapeutic Class (Value)
        • 7.2.4.1. Non-Opioids
        • 7.2.4.2. Opioids
      • 7.2.5. Global Topical Analgesics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Topical Analgesics (Volume)
      • 7.3.1. Global Topical Analgesics by: Type (Volume)
        • 7.3.1.1. Prescription Pain Relief
        • 7.3.1.2. Over-The-Counter Pain Relief
      • 7.3.2. Global Topical Analgesics by: Distribution Channel (Volume)
        • 7.3.2.1. Pharmacies & Drug Stores
        • 7.3.2.2. E-Commerce
        • 7.3.2.3. Retail & Grocery Stores
      • 7.3.3. Global Topical Analgesics by: Formulation (Volume)
        • 7.3.3.1. Cream
        • 7.3.3.2. Gel
        • 7.3.3.3. Spray
        • 7.3.3.4. Patch
        • 7.3.3.5. Others
      • 7.3.4. Global Topical Analgesics by: Therapeutic Class (Volume)
        • 7.3.4.1. Non-Opioids
        • 7.3.4.2. Opioids
      • 7.3.5. Global Topical Analgesics Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Topical Analgesics (Price)
      • 7.4.1. Global Topical Analgesics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Topical Analgesics: by Type(USD Million)
  • Table 2. Topical Analgesics Prescription Pain Relief , by Region USD Million (2018-2023)
  • Table 3. Topical Analgesics Over-The-Counter Pain Relief , by Region USD Million (2018-2023)
  • Table 4. Topical Analgesics: by Distribution Channel(USD Million)
  • Table 5. Topical Analgesics Pharmacies & Drug Stores , by Region USD Million (2018-2023)
  • Table 6. Topical Analgesics E-Commerce , by Region USD Million (2018-2023)
  • Table 7. Topical Analgesics Retail & Grocery Stores , by Region USD Million (2018-2023)
  • Table 8. Topical Analgesics: by Formulation(USD Million)
  • Table 9. Topical Analgesics Cream , by Region USD Million (2018-2023)
  • Table 10. Topical Analgesics Gel , by Region USD Million (2018-2023)
  • Table 11. Topical Analgesics Spray , by Region USD Million (2018-2023)
  • Table 12. Topical Analgesics Patch , by Region USD Million (2018-2023)
  • Table 13. Topical Analgesics Others , by Region USD Million (2018-2023)
  • Table 14. Topical Analgesics: by Therapeutic Class(USD Million)
  • Table 15. Topical Analgesics Non-Opioids , by Region USD Million (2018-2023)
  • Table 16. Topical Analgesics Opioids , by Region USD Million (2018-2023)
  • Table 17. South America Topical Analgesics, by Country USD Million (2018-2023)
  • Table 18. South America Topical Analgesics, by Type USD Million (2018-2023)
  • Table 19. South America Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 20. South America Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 21. South America Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 22. Brazil Topical Analgesics, by Type USD Million (2018-2023)
  • Table 23. Brazil Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 24. Brazil Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 25. Brazil Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 26. Argentina Topical Analgesics, by Type USD Million (2018-2023)
  • Table 27. Argentina Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 28. Argentina Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 29. Argentina Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 30. Rest of South America Topical Analgesics, by Type USD Million (2018-2023)
  • Table 31. Rest of South America Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 32. Rest of South America Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 33. Rest of South America Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 34. Asia Pacific Topical Analgesics, by Country USD Million (2018-2023)
  • Table 35. Asia Pacific Topical Analgesics, by Type USD Million (2018-2023)
  • Table 36. Asia Pacific Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 37. Asia Pacific Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 38. Asia Pacific Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 39. China Topical Analgesics, by Type USD Million (2018-2023)
  • Table 40. China Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 41. China Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 42. China Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 43. Japan Topical Analgesics, by Type USD Million (2018-2023)
  • Table 44. Japan Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 45. Japan Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 46. Japan Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 47. India Topical Analgesics, by Type USD Million (2018-2023)
  • Table 48. India Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 49. India Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 50. India Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 51. South Korea Topical Analgesics, by Type USD Million (2018-2023)
  • Table 52. South Korea Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 53. South Korea Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 54. South Korea Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 55. Taiwan Topical Analgesics, by Type USD Million (2018-2023)
  • Table 56. Taiwan Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 57. Taiwan Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 58. Taiwan Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 59. Australia Topical Analgesics, by Type USD Million (2018-2023)
  • Table 60. Australia Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 61. Australia Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 62. Australia Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Topical Analgesics, by Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 67. Europe Topical Analgesics, by Country USD Million (2018-2023)
  • Table 68. Europe Topical Analgesics, by Type USD Million (2018-2023)
  • Table 69. Europe Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 70. Europe Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 71. Europe Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 72. Germany Topical Analgesics, by Type USD Million (2018-2023)
  • Table 73. Germany Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 74. Germany Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 75. Germany Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 76. France Topical Analgesics, by Type USD Million (2018-2023)
  • Table 77. France Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 78. France Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 79. France Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 80. Italy Topical Analgesics, by Type USD Million (2018-2023)
  • Table 81. Italy Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 82. Italy Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 83. Italy Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 84. United Kingdom Topical Analgesics, by Type USD Million (2018-2023)
  • Table 85. United Kingdom Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 86. United Kingdom Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 87. United Kingdom Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 88. Netherlands Topical Analgesics, by Type USD Million (2018-2023)
  • Table 89. Netherlands Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 90. Netherlands Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 91. Netherlands Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 92. Rest of Europe Topical Analgesics, by Type USD Million (2018-2023)
  • Table 93. Rest of Europe Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 94. Rest of Europe Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 95. Rest of Europe Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 96. MEA Topical Analgesics, by Country USD Million (2018-2023)
  • Table 97. MEA Topical Analgesics, by Type USD Million (2018-2023)
  • Table 98. MEA Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 99. MEA Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 100. MEA Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 101. Middle East Topical Analgesics, by Type USD Million (2018-2023)
  • Table 102. Middle East Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 103. Middle East Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 104. Middle East Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 105. Africa Topical Analgesics, by Type USD Million (2018-2023)
  • Table 106. Africa Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 107. Africa Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 108. Africa Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 109. North America Topical Analgesics, by Country USD Million (2018-2023)
  • Table 110. North America Topical Analgesics, by Type USD Million (2018-2023)
  • Table 111. North America Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 112. North America Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 113. North America Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 114. United States Topical Analgesics, by Type USD Million (2018-2023)
  • Table 115. United States Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 116. United States Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 117. United States Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 118. Canada Topical Analgesics, by Type USD Million (2018-2023)
  • Table 119. Canada Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 120. Canada Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 121. Canada Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 122. Mexico Topical Analgesics, by Type USD Million (2018-2023)
  • Table 123. Mexico Topical Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 124. Mexico Topical Analgesics, by Formulation USD Million (2018-2023)
  • Table 125. Mexico Topical Analgesics, by Therapeutic Class USD Million (2018-2023)
  • Table 126. Topical Analgesics Sales: by Type(K Units)
  • Table 127. Topical Analgesics Sales Prescription Pain Relief , by Region K Units (2018-2023)
  • Table 128. Topical Analgesics Sales Over-The-Counter Pain Relief , by Region K Units (2018-2023)
  • Table 129. Topical Analgesics Sales: by Distribution Channel(K Units)
  • Table 130. Topical Analgesics Sales Pharmacies & Drug Stores , by Region K Units (2018-2023)
  • Table 131. Topical Analgesics Sales E-Commerce , by Region K Units (2018-2023)
  • Table 132. Topical Analgesics Sales Retail & Grocery Stores , by Region K Units (2018-2023)
  • Table 133. Topical Analgesics Sales: by Formulation(K Units)
  • Table 134. Topical Analgesics Sales Cream , by Region K Units (2018-2023)
  • Table 135. Topical Analgesics Sales Gel , by Region K Units (2018-2023)
  • Table 136. Topical Analgesics Sales Spray , by Region K Units (2018-2023)
  • Table 137. Topical Analgesics Sales Patch , by Region K Units (2018-2023)
  • Table 138. Topical Analgesics Sales Others , by Region K Units (2018-2023)
  • Table 139. Topical Analgesics Sales: by Therapeutic Class(K Units)
  • Table 140. Topical Analgesics Sales Non-Opioids , by Region K Units (2018-2023)
  • Table 141. Topical Analgesics Sales Opioids , by Region K Units (2018-2023)
  • Table 142. South America Topical Analgesics Sales, by Country K Units (2018-2023)
  • Table 143. South America Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 144. South America Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 145. South America Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 146. South America Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 147. Brazil Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 148. Brazil Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 149. Brazil Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 150. Brazil Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 151. Argentina Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 152. Argentina Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 153. Argentina Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 154. Argentina Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 155. Rest of South America Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 156. Rest of South America Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 157. Rest of South America Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 158. Rest of South America Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 159. Asia Pacific Topical Analgesics Sales, by Country K Units (2018-2023)
  • Table 160. Asia Pacific Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 161. Asia Pacific Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 162. Asia Pacific Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 163. Asia Pacific Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 164. China Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 165. China Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 166. China Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 167. China Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 168. Japan Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 169. Japan Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 170. Japan Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 171. Japan Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 172. India Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 173. India Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 174. India Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 175. India Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 176. South Korea Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 177. South Korea Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 178. South Korea Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 179. South Korea Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 180. Taiwan Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 181. Taiwan Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 182. Taiwan Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 183. Taiwan Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 184. Australia Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 185. Australia Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 186. Australia Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 187. Australia Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 188. Rest of Asia-Pacific Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 189. Rest of Asia-Pacific Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 190. Rest of Asia-Pacific Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 191. Rest of Asia-Pacific Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 192. Europe Topical Analgesics Sales, by Country K Units (2018-2023)
  • Table 193. Europe Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 194. Europe Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 195. Europe Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 196. Europe Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 197. Germany Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 198. Germany Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 199. Germany Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 200. Germany Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 201. France Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 202. France Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 203. France Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 204. France Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 205. Italy Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 206. Italy Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 207. Italy Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 208. Italy Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 209. United Kingdom Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 210. United Kingdom Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 211. United Kingdom Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 212. United Kingdom Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 213. Netherlands Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 214. Netherlands Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 215. Netherlands Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 216. Netherlands Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 217. Rest of Europe Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 218. Rest of Europe Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 219. Rest of Europe Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 220. Rest of Europe Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 221. MEA Topical Analgesics Sales, by Country K Units (2018-2023)
  • Table 222. MEA Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 223. MEA Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 224. MEA Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 225. MEA Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 226. Middle East Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 227. Middle East Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 228. Middle East Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 229. Middle East Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 230. Africa Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 231. Africa Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 232. Africa Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 233. Africa Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 234. North America Topical Analgesics Sales, by Country K Units (2018-2023)
  • Table 235. North America Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 236. North America Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 237. North America Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 238. North America Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 239. United States Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 240. United States Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 241. United States Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 242. United States Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 243. Canada Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 244. Canada Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 245. Canada Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 246. Canada Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 247. Mexico Topical Analgesics Sales, by Type K Units (2018-2023)
  • Table 248. Mexico Topical Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 249. Mexico Topical Analgesics Sales, by Formulation K Units (2018-2023)
  • Table 250. Mexico Topical Analgesics Sales, by Therapeutic Class K Units (2018-2023)
  • Table 251. Topical Analgesics: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Topical Analgesics: by Type(USD Million)
  • Table 261. Topical Analgesics Prescription Pain Relief , by Region USD Million (2025-2030)
  • Table 262. Topical Analgesics Over-The-Counter Pain Relief , by Region USD Million (2025-2030)
  • Table 263. Topical Analgesics: by Distribution Channel(USD Million)
  • Table 264. Topical Analgesics Pharmacies & Drug Stores , by Region USD Million (2025-2030)
  • Table 265. Topical Analgesics E-Commerce , by Region USD Million (2025-2030)
  • Table 266. Topical Analgesics Retail & Grocery Stores , by Region USD Million (2025-2030)
  • Table 267. Topical Analgesics: by Formulation(USD Million)
  • Table 268. Topical Analgesics Cream , by Region USD Million (2025-2030)
  • Table 269. Topical Analgesics Gel , by Region USD Million (2025-2030)
  • Table 270. Topical Analgesics Spray , by Region USD Million (2025-2030)
  • Table 271. Topical Analgesics Patch , by Region USD Million (2025-2030)
  • Table 272. Topical Analgesics Others , by Region USD Million (2025-2030)
  • Table 273. Topical Analgesics: by Therapeutic Class(USD Million)
  • Table 274. Topical Analgesics Non-Opioids , by Region USD Million (2025-2030)
  • Table 275. Topical Analgesics Opioids , by Region USD Million (2025-2030)
  • Table 276. South America Topical Analgesics, by Country USD Million (2025-2030)
  • Table 277. South America Topical Analgesics, by Type USD Million (2025-2030)
  • Table 278. South America Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 279. South America Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 280. South America Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 281. Brazil Topical Analgesics, by Type USD Million (2025-2030)
  • Table 282. Brazil Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 283. Brazil Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 284. Brazil Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 285. Argentina Topical Analgesics, by Type USD Million (2025-2030)
  • Table 286. Argentina Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 287. Argentina Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 288. Argentina Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 289. Rest of South America Topical Analgesics, by Type USD Million (2025-2030)
  • Table 290. Rest of South America Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 291. Rest of South America Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 292. Rest of South America Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 293. Asia Pacific Topical Analgesics, by Country USD Million (2025-2030)
  • Table 294. Asia Pacific Topical Analgesics, by Type USD Million (2025-2030)
  • Table 295. Asia Pacific Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 296. Asia Pacific Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 297. Asia Pacific Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 298. China Topical Analgesics, by Type USD Million (2025-2030)
  • Table 299. China Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 300. China Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 301. China Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 302. Japan Topical Analgesics, by Type USD Million (2025-2030)
  • Table 303. Japan Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 304. Japan Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 305. Japan Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 306. India Topical Analgesics, by Type USD Million (2025-2030)
  • Table 307. India Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 308. India Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 309. India Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 310. South Korea Topical Analgesics, by Type USD Million (2025-2030)
  • Table 311. South Korea Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 312. South Korea Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 313. South Korea Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 314. Taiwan Topical Analgesics, by Type USD Million (2025-2030)
  • Table 315. Taiwan Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 316. Taiwan Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 317. Taiwan Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 318. Australia Topical Analgesics, by Type USD Million (2025-2030)
  • Table 319. Australia Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 320. Australia Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 321. Australia Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 322. Rest of Asia-Pacific Topical Analgesics, by Type USD Million (2025-2030)
  • Table 323. Rest of Asia-Pacific Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 324. Rest of Asia-Pacific Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 325. Rest of Asia-Pacific Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 326. Europe Topical Analgesics, by Country USD Million (2025-2030)
  • Table 327. Europe Topical Analgesics, by Type USD Million (2025-2030)
  • Table 328. Europe Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 329. Europe Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 330. Europe Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 331. Germany Topical Analgesics, by Type USD Million (2025-2030)
  • Table 332. Germany Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 333. Germany Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 334. Germany Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 335. France Topical Analgesics, by Type USD Million (2025-2030)
  • Table 336. France Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 337. France Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 338. France Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 339. Italy Topical Analgesics, by Type USD Million (2025-2030)
  • Table 340. Italy Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 341. Italy Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 342. Italy Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 343. United Kingdom Topical Analgesics, by Type USD Million (2025-2030)
  • Table 344. United Kingdom Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 345. United Kingdom Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 346. United Kingdom Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 347. Netherlands Topical Analgesics, by Type USD Million (2025-2030)
  • Table 348. Netherlands Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 349. Netherlands Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 350. Netherlands Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 351. Rest of Europe Topical Analgesics, by Type USD Million (2025-2030)
  • Table 352. Rest of Europe Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 353. Rest of Europe Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 354. Rest of Europe Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 355. MEA Topical Analgesics, by Country USD Million (2025-2030)
  • Table 356. MEA Topical Analgesics, by Type USD Million (2025-2030)
  • Table 357. MEA Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 358. MEA Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 359. MEA Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 360. Middle East Topical Analgesics, by Type USD Million (2025-2030)
  • Table 361. Middle East Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 362. Middle East Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 363. Middle East Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 364. Africa Topical Analgesics, by Type USD Million (2025-2030)
  • Table 365. Africa Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 366. Africa Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 367. Africa Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 368. North America Topical Analgesics, by Country USD Million (2025-2030)
  • Table 369. North America Topical Analgesics, by Type USD Million (2025-2030)
  • Table 370. North America Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 371. North America Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 372. North America Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 373. United States Topical Analgesics, by Type USD Million (2025-2030)
  • Table 374. United States Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 375. United States Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 376. United States Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 377. Canada Topical Analgesics, by Type USD Million (2025-2030)
  • Table 378. Canada Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 379. Canada Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 380. Canada Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 381. Mexico Topical Analgesics, by Type USD Million (2025-2030)
  • Table 382. Mexico Topical Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 383. Mexico Topical Analgesics, by Formulation USD Million (2025-2030)
  • Table 384. Mexico Topical Analgesics, by Therapeutic Class USD Million (2025-2030)
  • Table 385. Topical Analgesics Sales: by Type(K Units)
  • Table 386. Topical Analgesics Sales Prescription Pain Relief , by Region K Units (2025-2030)
  • Table 387. Topical Analgesics Sales Over-The-Counter Pain Relief , by Region K Units (2025-2030)
  • Table 388. Topical Analgesics Sales: by Distribution Channel(K Units)
  • Table 389. Topical Analgesics Sales Pharmacies & Drug Stores , by Region K Units (2025-2030)
  • Table 390. Topical Analgesics Sales E-Commerce , by Region K Units (2025-2030)
  • Table 391. Topical Analgesics Sales Retail & Grocery Stores , by Region K Units (2025-2030)
  • Table 392. Topical Analgesics Sales: by Formulation(K Units)
  • Table 393. Topical Analgesics Sales Cream , by Region K Units (2025-2030)
  • Table 394. Topical Analgesics Sales Gel , by Region K Units (2025-2030)
  • Table 395. Topical Analgesics Sales Spray , by Region K Units (2025-2030)
  • Table 396. Topical Analgesics Sales Patch , by Region K Units (2025-2030)
  • Table 397. Topical Analgesics Sales Others , by Region K Units (2025-2030)
  • Table 398. Topical Analgesics Sales: by Therapeutic Class(K Units)
  • Table 399. Topical Analgesics Sales Non-Opioids , by Region K Units (2025-2030)
  • Table 400. Topical Analgesics Sales Opioids , by Region K Units (2025-2030)
  • Table 401. South America Topical Analgesics Sales, by Country K Units (2025-2030)
  • Table 402. South America Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 403. South America Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 404. South America Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 405. South America Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 406. Brazil Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 407. Brazil Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 408. Brazil Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 409. Brazil Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 410. Argentina Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 411. Argentina Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 412. Argentina Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 413. Argentina Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 414. Rest of South America Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 415. Rest of South America Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 416. Rest of South America Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 417. Rest of South America Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 418. Asia Pacific Topical Analgesics Sales, by Country K Units (2025-2030)
  • Table 419. Asia Pacific Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 420. Asia Pacific Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 421. Asia Pacific Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 422. Asia Pacific Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 423. China Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 424. China Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 425. China Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 426. China Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 427. Japan Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 428. Japan Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 429. Japan Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 430. Japan Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 431. India Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 432. India Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 433. India Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 434. India Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 435. South Korea Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 436. South Korea Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 437. South Korea Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 438. South Korea Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 439. Taiwan Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 440. Taiwan Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 441. Taiwan Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 442. Taiwan Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 443. Australia Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 444. Australia Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 445. Australia Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 446. Australia Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 447. Rest of Asia-Pacific Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 448. Rest of Asia-Pacific Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 449. Rest of Asia-Pacific Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 450. Rest of Asia-Pacific Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 451. Europe Topical Analgesics Sales, by Country K Units (2025-2030)
  • Table 452. Europe Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 453. Europe Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 454. Europe Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 455. Europe Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 456. Germany Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 457. Germany Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 458. Germany Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 459. Germany Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 460. France Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 461. France Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 462. France Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 463. France Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 464. Italy Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 465. Italy Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 466. Italy Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 467. Italy Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 468. United Kingdom Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 469. United Kingdom Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 470. United Kingdom Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 471. United Kingdom Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 472. Netherlands Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 473. Netherlands Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 474. Netherlands Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 475. Netherlands Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 476. Rest of Europe Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 477. Rest of Europe Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 478. Rest of Europe Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 479. Rest of Europe Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 480. MEA Topical Analgesics Sales, by Country K Units (2025-2030)
  • Table 481. MEA Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 482. MEA Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 483. MEA Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 484. MEA Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 485. Middle East Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 486. Middle East Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 487. Middle East Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 488. Middle East Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 489. Africa Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 490. Africa Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 491. Africa Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 492. Africa Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 493. North America Topical Analgesics Sales, by Country K Units (2025-2030)
  • Table 494. North America Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 495. North America Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 496. North America Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 497. North America Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 498. United States Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 499. United States Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 500. United States Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 501. United States Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 502. Canada Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 503. Canada Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 504. Canada Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 505. Canada Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 506. Mexico Topical Analgesics Sales, by Type K Units (2025-2030)
  • Table 507. Mexico Topical Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 508. Mexico Topical Analgesics Sales, by Formulation K Units (2025-2030)
  • Table 509. Mexico Topical Analgesics Sales, by Therapeutic Class K Units (2025-2030)
  • Table 510. Topical Analgesics: by Type(USD/Units)
  • Table 511. Research Programs/Design for This Report
  • Table 512. Key Data Information from Secondary Sources
  • Table 513. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Topical Analgesics: by Type USD Million (2018-2023)
  • Figure 5. Global Topical Analgesics: by Distribution Channel USD Million (2018-2023)
  • Figure 6. Global Topical Analgesics: by Formulation USD Million (2018-2023)
  • Figure 7. Global Topical Analgesics: by Therapeutic Class USD Million (2018-2023)
  • Figure 8. South America Topical Analgesics Share (%), by Country
  • Figure 9. Asia Pacific Topical Analgesics Share (%), by Country
  • Figure 10. Europe Topical Analgesics Share (%), by Country
  • Figure 11. MEA Topical Analgesics Share (%), by Country
  • Figure 12. North America Topical Analgesics Share (%), by Country
  • Figure 13. Global Topical Analgesics: by Type K Units (2018-2023)
  • Figure 14. Global Topical Analgesics: by Distribution Channel K Units (2018-2023)
  • Figure 15. Global Topical Analgesics: by Formulation K Units (2018-2023)
  • Figure 16. Global Topical Analgesics: by Therapeutic Class K Units (2018-2023)
  • Figure 17. South America Topical Analgesics Share (%), by Country
  • Figure 18. Asia Pacific Topical Analgesics Share (%), by Country
  • Figure 19. Europe Topical Analgesics Share (%), by Country
  • Figure 20. MEA Topical Analgesics Share (%), by Country
  • Figure 21. North America Topical Analgesics Share (%), by Country
  • Figure 22. Global Topical Analgesics: by Type USD/Units (2018-2023)
  • Figure 23. Global Topical Analgesics share by Players 2023 (%)
  • Figure 24. Global Topical Analgesics share by Players (Top 3) 2023(%)
  • Figure 25. Global Topical Analgesics share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 29. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 31. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2023
  • Figure 33. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Reckitt Benckiser Group Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Reckitt Benckiser Group Plc. (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 38. Sanofi S.A. (France) Revenue: by Geography 2023
  • Figure 39. Topical BioMedics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Topical BioMedics, Inc. (United States) Revenue: by Geography 2023
  • Figure 41. AdvaCare Pharma (China) Revenue, Net Income and Gross profit
  • Figure 42. AdvaCare Pharma (China) Revenue: by Geography 2023
  • Figure 43. Global Topical Analgesics: by Type USD Million (2025-2030)
  • Figure 44. Global Topical Analgesics: by Distribution Channel USD Million (2025-2030)
  • Figure 45. Global Topical Analgesics: by Formulation USD Million (2025-2030)
  • Figure 46. Global Topical Analgesics: by Therapeutic Class USD Million (2025-2030)
  • Figure 47. South America Topical Analgesics Share (%), by Country
  • Figure 48. Asia Pacific Topical Analgesics Share (%), by Country
  • Figure 49. Europe Topical Analgesics Share (%), by Country
  • Figure 50. MEA Topical Analgesics Share (%), by Country
  • Figure 51. North America Topical Analgesics Share (%), by Country
  • Figure 52. Global Topical Analgesics: by Type K Units (2025-2030)
  • Figure 53. Global Topical Analgesics: by Distribution Channel K Units (2025-2030)
  • Figure 54. Global Topical Analgesics: by Formulation K Units (2025-2030)
  • Figure 55. Global Topical Analgesics: by Therapeutic Class K Units (2025-2030)
  • Figure 56. South America Topical Analgesics Share (%), by Country
  • Figure 57. Asia Pacific Topical Analgesics Share (%), by Country
  • Figure 58. Europe Topical Analgesics Share (%), by Country
  • Figure 59. MEA Topical Analgesics Share (%), by Country
  • Figure 60. North America Topical Analgesics Share (%), by Country
  • Figure 61. Global Topical Analgesics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline Plc. (United Kingdom)
  • Pfizer Inc. (United States)
  • Reckitt Benckiser Group Plc. (United Kingdom)
  • Sanofi S.A. (France)
  • Topical BioMedics, Inc. (United States)
  • AdvaCare Pharma (China)
Additional players considered in the study are as follows:
Sun Pharmaceutical Industries Ltd. (India) , Abacus Health Products, Inc. (Canada) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 158 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Topical Analgesics Quantitative research analysis
Global Topical Analgesics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Johnson & Johnson (United States), Novartis AG (Switzerland), GlaxoSmithKline Plc. (United Kingdom), Pfizer Inc. (United States), Reckitt Benckiser Group Plc. (United Kingdom), Sanofi S.A. (France), Topical BioMedics, Inc. (United States) and AdvaCare Pharma (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Online Purchasing Trends across the Globe" is seen as one of major influencing trends for Topical Analgesics Market during projected period 2023-2030.
The Topical Analgesics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Topical Analgesics Report?

Have a Query? Click Here

Other Related Reports

Functional Powder Drinks Comprehensive Study by Type (Organic, Conventional), Distribution Channel (Online Stores, Hypermarket/Supermarket, Offline Retail Stores, Other Convenience Stores), Ingredien...
$ 3650
Open Heel Nursing Clogs Comprehensive Study by Type (Wooden Upper Clog, Wooden Soled Clog, Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers), Distribution Channel (Online, Offlin...
$ 3450
Pharmaceuticals Pouch Comprehensive Study by Type (Tamper Evident Pouches, High Barrier / Chemical Resistant Pouches, Breathable Pouches, Non-Peelable Pouches, Peelable Pouch), Application (Pharmaceu...
$ 3750
Eye Health Ingredients Comprehensive Study by Type (Lutein, Zeaxanthin, Vitamin A, Beta-carotene, Bilberry extracts, Other), Application (Pharmaceuticals, Supplements, Beverages, Oils and Fats, Baker...
$ 3650
Wearable Patch Comprehensive Study by Type (Temperature Patch, Blood Glucose Patch, Blood Pressure/Flow Patch, Heart Rate Patch, ECG Patch, Blood Oxygen Patch, Others (Position Sensor, Sweat Analyzer...
$ 3750
Cough Syrup Comprehensive Study by Application (Adults, Children), Category (Cough Suppressants, Expectorants), Distribution Channels (Pharmacies, Grocery Stores, Health Food Shops, Internet Sales, M...
$ 3750